Rituximab after ASCT boosted survival in mantle cell lymphomaJanuary 21, 2017Lymphoma & Plasma Cell Disorders
VIDEO: First multicenter trial of CAR T cells shows response in DLBCLJanuary 19, 2017Lymphoma & Plasma Cell Disorders
Bortezomib bolsters hematologic response in AL amyloidosisJanuary 18, 2017Lymphoma & Plasma Cell Disorders
Daratumumab combo holds up across POLLUX myeloma subgroupsJanuary 5, 2017Lymphoma & Plasma Cell Disorders
Autologous stem cell transplantation beat bortezomib regimen in myelomaDecember 13, 2016Lymphoma & Plasma Cell Disorders
Study reinforces lenalidomide maintenance in newly diagnosed multiple myelomaDecember 11, 2016Lymphoma & Plasma Cell Disorders
Second transplant, consolidation don’t add benefit in upfront multiple myeloma therapyDecember 6, 2016Lymphoma & Plasma Cell Disorders
Brentuximab vedotin beat methotrexate, bexarotene in cutaneous T-cell lymphomaDecember 6, 2016Rare DiseasesLymphoma & Plasma Cell Disorders
VIDEO: Obinutuzumab bests rituximab for PFS in follicular lymphomaDecember 6, 2016Lymphoma & Plasma Cell DisordersFollicular Lymphoma
Antibody face-off in follicular lymphoma gives PFS, but not OS, edge to obinutuzumabDecember 5, 2016Lymphoma & Plasma Cell DisordersFollicular Lymphoma
VIDEO: Venetoclax shows early good results in multiple myelomaDecember 4, 2016Lymphoma & Plasma Cell Disorders
